NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|227500367|ref|NP_036274|]
View 

cyclin-D1-binding protein 1 [Homo sapiens]

Protein Classification

cyclin-D1-binding protein 1( domain architecture ID 10594744)

cyclin-D1-binding protein 1 may negatively regulate cell cycle progression, and act at least in part via inhibition of the cyclin-D1/CDK4 complex, thereby preventing phosphorylation of RB1 and blocking E2F-dependent transcription

Gene Ontology:  GO:0051726
SCOP:  4007841|4006148

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
GCIP pfam13324
Grap2 and cyclin-D-interacting; GCIP, or Grap2 and cyclin-D-interacting protein, is found in ...
55-320 2.22e-99

Grap2 and cyclin-D-interacting; GCIP, or Grap2 and cyclin-D-interacting protein, is found in eukaryotes, and in the protein Swiss:O95273, residues 149-190 constitute a helix-loop-helix domain, residues 190-240 an acidic region, and 240-261 a leucine zipper domain. GCIP interacts with full-length Grap2 protein and with the COOH-terminal unique and SH3 domains (designated QC domain) of Grap2. It is potentially involved in the regulation of cell differentiation and proliferation through Grap2 and cyclin D-mediated signalling pathways. In mice, it is involved in G1/S-phase progression of hepatocytes, which in older animals is associated with the development of liver tumours. In vitro it acts as an inhibitory HLH protein, for example, blocking transcription of the HNF-4 promoter. In its function as a cyclin D1-binding protein it is able to reduce CDK4-mediated phosphorylation of the retinoblastoma protein and to inhibit E2F-mediated transcriptional activity. GCIP has also been shown to have interact physically with Rad (Ras associated with diabetes), Rad being important in regulating cellular senescence.


:

Pssm-ID: 463844  Cd Length: 261  Bit Score: 294.59  E-value: 2.22e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367   55 RLNEAAVTVSREATTLTIVFSQLPLPSPQETQKFCEQVHAAIKAFIAVYYLLPKDQGITLRKLVRGATLDIVDGMAQLME 134
Cdd:pfam13324   1 ELGKLAKLVSAEATKLGLLFSPPPLPSAEELQELMESIFNALSGLLLICHGLPKGQGPTLRKSVRSAVKQVVDGSAQLLE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367  135 V-LSVTPTQSPENNDLISYNSVWVACQQMPQIPRDNKAAALLMLTKNVDFVKDAHEEMEQAVEE----CDPYSGLLndte 209
Cdd:pfam13324  81 EiVSSYPSGSKDEEQLISTGSVWEACDALKKLPKDNKTAIGRAITEVLGLVKDALEEMEELLEDpegdEDPDEDDL---- 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367  210 ennsdnhnhEDDVLGFPSNQDLYWSEDDQELIIPCLALVRASKACLKKIRMLVAENGKKD---QVAQLDDIVDISDEISP 286
Cdd:pfam13324 157 ---------DDDEDEFRGNQDTYLSEEEMEVAKAVLGLLKATKALLKKLSRSITGEGKGDspeQVAQLDDLLDLCQEISP 227
                         250       260       270
                  ....*....|....*....|....*....|....
gi 227500367  287 SVDDLALSIYPPMCHLTVRINSAKLVSVLKKALE 320
Cdd:pfam13324 228 QVDDLGASVYPPQDFSAVKSNIEKLASVLKKMLE 261
 
Name Accession Description Interval E-value
GCIP pfam13324
Grap2 and cyclin-D-interacting; GCIP, or Grap2 and cyclin-D-interacting protein, is found in ...
55-320 2.22e-99

Grap2 and cyclin-D-interacting; GCIP, or Grap2 and cyclin-D-interacting protein, is found in eukaryotes, and in the protein Swiss:O95273, residues 149-190 constitute a helix-loop-helix domain, residues 190-240 an acidic region, and 240-261 a leucine zipper domain. GCIP interacts with full-length Grap2 protein and with the COOH-terminal unique and SH3 domains (designated QC domain) of Grap2. It is potentially involved in the regulation of cell differentiation and proliferation through Grap2 and cyclin D-mediated signalling pathways. In mice, it is involved in G1/S-phase progression of hepatocytes, which in older animals is associated with the development of liver tumours. In vitro it acts as an inhibitory HLH protein, for example, blocking transcription of the HNF-4 promoter. In its function as a cyclin D1-binding protein it is able to reduce CDK4-mediated phosphorylation of the retinoblastoma protein and to inhibit E2F-mediated transcriptional activity. GCIP has also been shown to have interact physically with Rad (Ras associated with diabetes), Rad being important in regulating cellular senescence.


Pssm-ID: 463844  Cd Length: 261  Bit Score: 294.59  E-value: 2.22e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367   55 RLNEAAVTVSREATTLTIVFSQLPLPSPQETQKFCEQVHAAIKAFIAVYYLLPKDQGITLRKLVRGATLDIVDGMAQLME 134
Cdd:pfam13324   1 ELGKLAKLVSAEATKLGLLFSPPPLPSAEELQELMESIFNALSGLLLICHGLPKGQGPTLRKSVRSAVKQVVDGSAQLLE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367  135 V-LSVTPTQSPENNDLISYNSVWVACQQMPQIPRDNKAAALLMLTKNVDFVKDAHEEMEQAVEE----CDPYSGLLndte 209
Cdd:pfam13324  81 EiVSSYPSGSKDEEQLISTGSVWEACDALKKLPKDNKTAIGRAITEVLGLVKDALEEMEELLEDpegdEDPDEDDL---- 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367  210 ennsdnhnhEDDVLGFPSNQDLYWSEDDQELIIPCLALVRASKACLKKIRMLVAENGKKD---QVAQLDDIVDISDEISP 286
Cdd:pfam13324 157 ---------DDDEDEFRGNQDTYLSEEEMEVAKAVLGLLKATKALLKKLSRSITGEGKGDspeQVAQLDDLLDLCQEISP 227
                         250       260       270
                  ....*....|....*....|....*....|....
gi 227500367  287 SVDDLALSIYPPMCHLTVRINSAKLVSVLKKALE 320
Cdd:pfam13324 228 QVDDLGASVYPPQDFSAVKSNIEKLASVLKKMLE 261
 
Name Accession Description Interval E-value
GCIP pfam13324
Grap2 and cyclin-D-interacting; GCIP, or Grap2 and cyclin-D-interacting protein, is found in ...
55-320 2.22e-99

Grap2 and cyclin-D-interacting; GCIP, or Grap2 and cyclin-D-interacting protein, is found in eukaryotes, and in the protein Swiss:O95273, residues 149-190 constitute a helix-loop-helix domain, residues 190-240 an acidic region, and 240-261 a leucine zipper domain. GCIP interacts with full-length Grap2 protein and with the COOH-terminal unique and SH3 domains (designated QC domain) of Grap2. It is potentially involved in the regulation of cell differentiation and proliferation through Grap2 and cyclin D-mediated signalling pathways. In mice, it is involved in G1/S-phase progression of hepatocytes, which in older animals is associated with the development of liver tumours. In vitro it acts as an inhibitory HLH protein, for example, blocking transcription of the HNF-4 promoter. In its function as a cyclin D1-binding protein it is able to reduce CDK4-mediated phosphorylation of the retinoblastoma protein and to inhibit E2F-mediated transcriptional activity. GCIP has also been shown to have interact physically with Rad (Ras associated with diabetes), Rad being important in regulating cellular senescence.


Pssm-ID: 463844  Cd Length: 261  Bit Score: 294.59  E-value: 2.22e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367   55 RLNEAAVTVSREATTLTIVFSQLPLPSPQETQKFCEQVHAAIKAFIAVYYLLPKDQGITLRKLVRGATLDIVDGMAQLME 134
Cdd:pfam13324   1 ELGKLAKLVSAEATKLGLLFSPPPLPSAEELQELMESIFNALSGLLLICHGLPKGQGPTLRKSVRSAVKQVVDGSAQLLE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367  135 V-LSVTPTQSPENNDLISYNSVWVACQQMPQIPRDNKAAALLMLTKNVDFVKDAHEEMEQAVEE----CDPYSGLLndte 209
Cdd:pfam13324  81 EiVSSYPSGSKDEEQLISTGSVWEACDALKKLPKDNKTAIGRAITEVLGLVKDALEEMEELLEDpegdEDPDEDDL---- 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 227500367  210 ennsdnhnhEDDVLGFPSNQDLYWSEDDQELIIPCLALVRASKACLKKIRMLVAENGKKD---QVAQLDDIVDISDEISP 286
Cdd:pfam13324 157 ---------DDDEDEFRGNQDTYLSEEEMEVAKAVLGLLKATKALLKKLSRSITGEGKGDspeQVAQLDDLLDLCQEISP 227
                         250       260       270
                  ....*....|....*....|....*....|....
gi 227500367  287 SVDDLALSIYPPMCHLTVRINSAKLVSVLKKALE 320
Cdd:pfam13324 228 QVDDLGASVYPPQDFSAVKSNIEKLASVLKKMLE 261
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH